Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion Read More
Syncona portfolio firm Freeline cuts workforce and narrows focus Read More
Syncona invests GBP19 million in Quell Therapeutics via funding round Read More
EXECUTIVE CHANGES: All change at Aura Energy amid ASX spin-out plan Read More
IN BRIEF: Syncona net assets drop as Life Science portfolio takes hit Read More
Syncona's Freeline loss widens but progresses on Fabry's disease drug Read More
TRADING UPDATES: Sealand's China progress; Altus finds gold Read More
Syncona's Autolus gets USD250 million investment from Blackstone Read More
UK earnings, trading statements calendar - next 7 days Read More
TRADING UPDATES: BATM signs new deal; Synectics wins two projects Read More
Syncona focuses on portfolio as net asset value drops in first quarter Read More
Syncona investee Freeline CEO Heggie leaves, COO Parini replaces Read More
UK shareholder meetings calendar - next 7 days Read More
Syncona investee Anaveon doses first patient in ANV419 trial Read More
Syncona gets boost in full-year from life science portfolio Read More
IN BRIEF: Syncona investee Freeline posts widened first quarter loss Read More
LONDON MARKET CLOSE: Equities rally after shocking US jobs undershoot Read More
LONDON MARKET MIDDAY: FTSE 100 hits 14-month high ahead of US jobs Read More
Syncona investee Gyroscope postpones US IPO citing "market conditions" Read More
